IFNB1 and infection: To test the utility of this system in anti-viral drug screening, we evaluated the efficacy of IFN-β, remdesivir, GC376, lopinavir, and ritonavir in inhibiting SARS-CoV-2 GFP/ΔN trVLP infection.